DNA double strand break repair: A radiation perspective

Antioxidants and Redox Signaling

Volumn 18, Issue 18, 2013, Pages 2458-2472

  Kavanagh, Joy N ^a   Redmond, Kelly M ^a   Schettino, Giuseppe ^a   Prise, Kevin M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BYSTANDER EFFECT; CANCER THERAPY; CELL FUNCTION; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EUKARYOTIC CELL; HUMAN; HYPOXIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION; REVIEW;

ANIMALS; BYSTANDER EFFECT; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPLICATION; HUMANS; NEOPLASMS; OXIDATIVE STRESS; RADIATION INJURIES;

EUKARYOTA;

EID: 84878616847     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5151     Document Type: Review

References (143)

1. Abraham RT. PI 3-kinase related kinases: "big" players in stress-induced signaling pathways. DNA Repair (Amst) 3: 883-887, 2004.
2. Ahn JY, Schwarz JK, Piwnica-Worms H, and Canman CE. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 60: 5934-5936, 2000.
3. Alexander BM, Wang XZ, Niemierko A, Weaver DT, Mak RH, Roof KS, Fidias P, Wain J, and Choi NC. DNA repair biomarkers predict response to neoadjuvant chemor-adiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys 83: 164-171, 2012.
4. Allen C, Halbrook J, and Nickoloff JA. Interactive competition between homologous recombination and non-homologous end joining. Mol Cancer Res 1: 913-920, 2003.
5. Asaithamby A, Hu B, and Chen DJ. Unrepaired clustered DNA lesions induce chromosome breakage in human cells. Proc Natl Acad Sci U S A 108: 8293-8298, 2011.
6. Asaithamby A, Uematsu N, Chatterjee A, Story MD, Burma S, and Chen DJ. Repair of HZE-particle-induced DNA double-strand breaks in normal human fibroblasts. Radiat Res 169: 437-446, 2008.
7. Bakkenist CJ, and Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506, 2003.
8. Bennett SM, Neher TM, Shatilla A, and Turchi JJ. Molecular analysis of Ku redox regulation. BMC Mol Biol 10: 86, 2009.
9. Bethe HA, and Ashkin J. Experimental Nuclear Physics. New York: J. Wiley, 1953.
10. Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, Pierce AJ, Bristow RG, Classon MK, and Glazer PM. Hy-poxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 65: 11597-11604, 2005.
11. Blasina A, Hallin J, Chen E, Arango ME, Kraynov E, Register J, Grant S, Ninkovic S, Chen P, Nichols T, O'Connor P, and Anderes K. Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. Mol Cancer Ther 7: 2394-2404, 2008.
12. Borst GR, McLaughlin M, Kyula JN, Neijenhuis S, Khan A, Good J, Zaidi S, Powell NG, Meier P, Collins I, Garrett MD, Verheij M, and Harrington KJ. Targeted radiosensitization by the Chk1 inhibitor SAR-020106. Int J Radiat Oncol Biol Phys (In Press), 2012.
13. Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q, Haffty BG, Tommiska J, Blomqvist C, Drapkin R, Adams DJ, Nevanlinna H, Bartek J, Tarsounas M, Ganesan S, and Jonkers J. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol 17: 688-695, 2010.
14. Bristow RG, and Hill RP. Hypoxia and metabolism. Hy-poxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180-192, 2008.
15. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, and Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917, 2005.
16. Burdak-Rothkamm S, Rothkamm K, and Prise KM. ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. Cancer Res 68: 7059-7065, 2008.
17. Byrd PJ, Srinivasan V, Last JI, Smith A, Biggs P, Carney EF, Exley A, Abson C, Stewart GS, Izatt L, and Taylor AM. Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia. Br J Cancer 106: 262-268, 2012.
18. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sa-kaguchi K, Appella E, Kastan MB, and Siliciano JD. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679, 1998.
19. Carson CT, Schwartz RA, Stracker TH, Lilley CE, Lee DV, and Weitzman MD. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J 22: 6610-6620, 2003.
20. Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, Qin J, and Chen DJ. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev 16: 2333-2338, 2002.
21. Cortez D, Wang Y, Qin J, and Elledge SJ. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286: 1162-1166, 1999.
22. Costes SV, Boissiere A, Ravani S, Romano R, Parvin B, and Barcellos-Hoff MH. Imaging features that discriminate between foci induced by high-and low-LET radiation in human fibroblasts. Radiat Res 165: 505-515, 2006.
23. Costes SV, Chiolo I, Pluth JM, Barcellos-Hoff MH, and Jakob B. Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization. Mutat Res 704: 78-87, 2010.
24. Couch FJ, Johnson MR, Rabe K, Boardman L, McWilliams R, de Andrade M, and Petersen G. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res 65: 383-386, 2005.
25. D'Amours D, and Jackson SP. The Mre11 complex: at the crossroads of dna repair and checkpoint signalling. Nat Rev Mol Cell Biol 3: 317-327, 2002.
26. Daemen A, Wolf DM, Korkola JE, Griffith OL, Frankum JR, Brough R, Jakkula LR, Wang NJ, Natrajan R, Reis-Filho JS, Lord CJ, Ashworth A, Spellman PT, Gray JW, and Van't Veer LJ. Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib. Breast Cancer Res Treat 135: 505-517, 2012.
27. DeFazio LG, Stansel RM, Griffith JD, and Chu G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J 21: 3192-3200, 2002.
28. Dery U, and Masson JY. Twists and turns in the function of DNA damage signaling and repair proteins by post-translational modifications. DNA Repair (Amst) 6: 561-577, 2007.
29. Desai S, Kumar A, Laskar S, and Pandey BN. Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells. Cytokine 61: 54-62, 2013.
30. Eccles LJ, O'Neill P, and Lomax ME. Delayed repair of radiation induced clustered DNA damage: friend or foe? Mutat Res 711: 134-141, 2011.
31. Eelen G, Vanden Bempt I, Verlinden L, Drijkoningen M, Smeets A, Neven P, Christiaens MR, Marchal K, Bouillon R, and Verstuyf A. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. Oncogene 27: 4233-4241, 2008.
32. Essers J, Hendriks RW, Swagemakers SM, Troelstra C, de Wit J, Bootsma D, Hoeijmakers JH, and Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89: 195-204, 1997.
33. Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenje H, Gluckman E, and Mathew CG. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood 96: 4064-4070, 2000.
34. Falck J, Coates J, and Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434: 605-611, 2005.
35. Falck J, Mailand N, Syljuasen RG, Bartek J, and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410: 842-847, 2001.
36. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, and Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005.
37. Ferrao PT, Bukczynska EP, Johnstone RW, and McArthur GA. Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells. Oncogene 31: 1661-1672, 2012.
38. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, and de Bono JS. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123-134, 2009.
39. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689, 1998.
40. Fujioka Y, Kimata Y, Nomaguchi K, Watanabe K, and Kohno K. Identification of a novel non-structural maintenance of chromosomes (SMC) component of the SMC5-SMC6 complex involved in DNA repair. J Biol Chem 277: 21585-21591, 2002.
41. Garcia MJ, Fernandez V, Osorio A, Barroso A, Fernandez F, Urioste M, and Benitez J. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 30: 1898-1902, 2009.
42. Gedik CM, and Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J 19: 82-84, 2005.
43. Gelmon KA, Tischkowitz M, Mackay H, Swenerton K, Robidoux A, Tonkin K, Hirte H, Huntsman D, Clemons M, Gilks B, Yerushalmi R, Macpherson E, Carmichael J, and Oza A. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. Lancet Oncol 12: 852-861, 2011.
44. Goncalves A, Finetti P, Sabatier R, Gilabert M, Adelaide J, Borg JP, Chaffanet M, Viens P, Birnbaum D, and Bertucci F. Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis. Breast Cancer Res Treat 127: 273-281, 2011.
45. Goodarzi AA, Jeggo P, and Lobrich M. The influence of heterochromatin on DNA double strand break repair: getting the strong, silent type to relax. DNA Repair (Amst) 9: 1273-1282, 2010.
46. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 65: 7-17, 1994.
47. Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, and Lieber MR. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388: 492-495, 1997.
48. Grawunder U, Zimmer D, and Leiber MR. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Curr Biol 8: 873-876, 1998.
49. Gulston M, de Lara C, Jenner T, Davis E, and O'Neill P. Processing of clustered DNA damage generates additional double-strand breaks in mammalian cells post-irradiation. Nucleic Acids Res 32: 1602-1609, 2004.
50. Guo Z, Kozlov S, Lavin MF, Person MD, and Paull TT. ATM activation by oxidative stress. Science 330: 517-521, 2010.
51. Haber JE. DNA repair. Gatekeepers of recombination. Nature 398: 665-667, 1999.
52. Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grutzmann R, Rehder H, Rothmund M, Schmiegel W, Neoptolemos JP, and Bartsch DK. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95: 214-221, 2003.
53. Hendrickson EA. Cell-cycle regulation of mammalian DNA double-strand-break repair. Am J Hum Genet 61: 795-800, 1997.
54. Hess CJ, Ameziane N, Schuurhuis GJ, Errami A, Denkers F, Kaspers GJ, Cloos J, Joenje H, Reinhardt D, Ossenkoppele GJ, Zwaan CM, and Waisfisz Q. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia. Cell Oncol 30: 299-306, 2008.
55. Holliday R. Recombination and meiosis. Philos Trans R Soc Lond B Biol Sci 277: 359-370, 1977.
56. Ip SC, Rass U, Blanco MG, Flynn HR, Skehel JM, and West SC. Identification of Holliday junction resolvases from humans and yeast. Nature 456: 357-361, 2008.
57. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23: 687-696, 2002.
58. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, and Jackson SP. ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8: 37-45, 2006.
59. Johzuka K, and Ogawa H. Interaction of Mre11 and Rad50: two proteins required for DNA repair and meiosis-specific double-strand break formation in Saccharomyces cerevisiae. Genetics 139: 1521-1532, 1995.
60. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iaco-buzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Vel-culescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, and Klein AP. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324: 217, 2009.
61. Junop MS, Modesti M, Guarne A, Ghirlando R, Gellert M, and Yang W. Crystal structure of the Xrcc4 DNA repair protein and implications for end joining. EMBO J 19: 5962-5970, 2000.
62. Karimi-Busheri F, Rasouli-Nia A, Allalunis-Turner J, and Weinfeld M. Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination. Cancer Res 67: 6619-6625, 2007.
63. Kaye SB, Lubinski J, Matulonis U, Ang JE, Gourley C, Karlan BY, Amnon A, Bell-McGuinn KM, Chen LM, Friedlander M, Safra T, Vergote I, Wickens M, Lowe ES, Carmichael J, and Kaufman B. Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer. J Clin Oncol 30: 372-379, 2012.
64. Kennedy RD, Chen CC, Stuckert P, Archila EM, De la Vega MA, Moreau LA, Shimamura A, and D'Andrea AD. Fan-coni anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest 117: 1440-1449, 2007.
65. Kennedy RD, and D'Andrea AD. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev 19: 2925-2940, 2005.
66. Khanna KK. Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst 92: 795-802, 2000.
67. Kim JS, Krasieva TB, Kurumizaka H, Chen DJ, Taylor AM, and Yokomori K. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J Cell Biol 170: 341-347, 2005.
68. Kitagawa R, Bakkenist CJ, McKinnon PJ, and Kastan MB. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev 18: 1423-1438, 2004.
69. Kortmann U, McAlpine JN, Xue H, Guan J, Ha G, Tully S, Shafait S, Lau A, Cranston AN, O'Connor MJ, Huntsman DG, Wang Y, and Gilks CB. Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts. Clin Cancer Res 17: 783-791, 2011.
70. Kryston TB, Georgiev AB, Pissis P, and Georgakilas AG. Role of oxidative stress and DNA damage in human car-cinogenesis. Mutat Res 711: 193-201, 2011.
71. Kuroda S, Urata Y, and Fujiwara T. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization. Acta Med Okayama 66: 83-92, 2012.
72. Lindahl T. Instability and decay of the primary structure of DNA. Nature 362: 709-715, 1993.
73. Lobrich M, and Jeggo PA. Harmonising the response to DSBs: a new string in the ATM bow. DNA Repair (Amst) 4: 749-759, 2005.
74. Luce A, Courtin A, Levalois C, Altmeyer-Morel S, Romeo PH, Chevillard S, and Lebeau J. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis 30: 432-439, 2009.
75. Lyng FM, Howe OL, and McClean B. Reactive oxygen species-induced release of signalling factors in irradiated cells triggers membrane signalling and calcium influx in bystander cells. Int J Radiat Biol 87: 683-695, 2011.
76. Mahaney BL, Meek K, and Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 417: 639-650, 2009.
77. Martin-Guerrero I, Enjuanes A, Richter J, Ammerpohl O, Colomer D, Ardanaz M, Marco F, Salas A, Campo E, Siebert R, and Garcia-Orad A. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk. Genes Chromosomes Cancer 50: 887-895, 2011.
78. Masson JY, Tarsounas MC, Stasiak AZ, Stasiak A, Shah R, McIlwraith MJ, Benson FE, and West SC. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 15: 3296-3307, 2001.
79. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, and Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166, 2007.
80. McVey M, and Lee SE. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet 24: 529-538, 2008.
81. Meek K, Dang V, and Lees-Miller SP. DNA-PK: the means to justify the ends? Adv Immunol 99: 33-58, 2008.
82. Meng AX, Jalali F, Cuddihy A, Chan N, Bindra RS, Glazer PM, and Bristow RG. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother Oncol 76: 168-176, 2005.
83. Mitchell JB, Choudhuri R, Fabre K, Sowers AL, Citrin D, Zabludoff SD, and Cook JA. In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762. Clin Cancer Res 16: 2076-2084, 2010.
84. Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Simeone DM, Canman CE, Normolle DP, Zabludoff SD, Maybaum J, and Lawrence TS. Mechanism of radio-sensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res 70: 4972-4981, 2010.
85. Mukherjee B, Tomimatsu N, Amancherla K, Camacho CV, Pichamoorthy N, and Burma S. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM-and DNA-PKCs-mediated DNA damage responses. Neoplasia 14: 34-43, 2012.
86. Nick McElhinny SA, Havener JM, Garcia-Diaz M, Juarez R, Bebenek K, Kee BL, Blanco L, Kunkel TA, and Ramsden DA. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomolo-gous end joining. Mol Cells 19: 357-366, 2005.
87. Okayasu R. Repair of DNA damage induced by accelerated heavy ions-a mini review. Int J Cancer 130: 991-1000, 2012.
88. Okayasu R, Okada M, Okabe A, Noguchi M, Takakura K, and Takahashi S. Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway. Radiat Res 165: 59-67, 2006.
89. Olcina M, Lecane PS, and Hammond EM. Targeting hyp-oxic cells through the DNA damage response. Clin Cancer Res 16: 5624-5629, 2010.
90. Park EJ, Chan DW, Park JH, Oettinger MA, and Kwon J. DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner. Nucleic Acids Res 31: 6819-6827, 2003.
91. Pasi F, Facoetti A, and Nano R. IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation. Anticancer Res 30: 2769-2772, 2010.
92. Paull TT. Saving the ends for last: the role of pol mu in DNA end joining. Mol Cells 19: 294-296, 2005.
93. Pires IM, Olcina MM, Anbalagan S, Pollard JR, Reaper PM, Charlton PA, McKenna WG, and Hammond EM. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition. Br J Cancer 107: 291-299, 2012.
94. Polo SE, and Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 25: 409-433, 2011.
95. Prise KM, Folkard M, Newman HC, and Michael BD. Effect of radiation quality on lesion complexity in cellular DNA. Int J Radiat Biol 66: 537-542, 1994.
96. Prise KM, and O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 9: 351-360, 2009.
97. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Easton DF, and Stratton MR. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165-167, 2007.
98. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, and Rahman N. ATM mutations that cause ataxia-telangi-ectasia are breast cancer susceptibility alleles. Nat Genet 38: 873-875, 2006.
99. Reynolds P, Anderson JA, Harper JV, Hill MA, Botchway SW, Parker AW, and O'Neill P. The dynamics of Ku70/80 and DNA-PKcs at DSBs induced by ionizing radiation is dependent on the complexity of damage. Nucleic Acids Res 40: 10821-10831, 2012.
100. Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ, Reis C, Dahm K, Fricke A, Krempler A, Parker AR, Jackson SP, Gennery A, Jeggo PA, and Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cells 16: 715-724, 2004.
101. Richard DJ, Bolderson E, Cubeddu L, Wadsworth RI, Savage K, Sharma GG, Nicolette ML, Tsvetanov S, McIlwraith MJ, Pandita RK, Takeda S, Hay RT, Gautier J, West SC, Paull TT, Pandita TK, White MF, and Khanna KK. Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 453: 677-681, 2008.
102. Richard DJ, Savage K, Bolderson E, Cubeddu L, So S, Ghita M, Chen DJ, White MF, Richard K, Prise KM, Schettino G, and Khanna KK. hSSB1 rapidly binds at the sites of DNA double-strand breaks and is required for the efficient recruitment of the MRN complex. Nucleic Acids Res 39: 1692-1702, 2011.
103. Richard DJ, Cubeddu L, Urguhart AJ, Bain A, Bolderson E, Menon D, White MF, Khanna KK. hSSB1 interacts directly with the MRN complex stimulating its recruitment to DNA double strand breaks and its endo-nuclease activity. Nucleic Acids Res 39:3643-51, 2011.
104. Riesterer O, Matsumoto F, Wang L, Pickett J, Molkentine D, Giri U, Milas L, and Raju U. A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe. Invest New Drugs 29: 514-522, 2011.
105. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, and Bonner WM. DNA double-stranded breaks induce histone H2AX phos-phorylation on serine 139. J Biol Chem 273: 5858-5868, 1998.
106. Roots R, Yang TC, Craise L, Blakely EA, and Tobias CA. Impaired repair capacity of DNA breaks induced in mammalian cellular DNA by accelerated heavy ions. Radiat Res 78: 38-49, 1979.
107. Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, Baer R, Lukas J, and Jackson SP. Human CtIP promotes DNA end resection. Nature 450: 509-514, 2007.
108. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vana-gaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, and Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
109. Shao C, Folkard M, and Prise KM. Role of TGF-beta1 and nitric oxide in the bystander response of irradiated glioma cells. Oncogene 27: 434-440, 2008.
110. Shrivastav M, De Haro LP, and Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res 18: 134-147, 2008.
111. Singleton BK, Torres-Arzayus MI, Rottinghaus ST, Taccioli GE, and Jeggo PA. The C terminus of Ku80 activates the DNA-dependent protein kinase catalytic subunit. Mol Cell Biol 19: 3267-3277, 1999.
112. Solyom S, Winqvist R, Nikkila J, Rapakko K, Hirvikoski P, Kokkonen H, and Pylkas K. Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family. Cancer Lett 302: 113-118, 2011.
113. Stenerlow B, Hoglund E, Elmroth K, Karlsson KH, and Radulescu I. Radiation quality dependence of DNA damage induction. Radiat Prot Dosim 99: 137-141, 2002.
114. Stewart GS, Wang B, Bignell CR, Taylor AM, and Elledge SJ. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421: 961-966, 2003.
115. Summers KC, Shen F, Sierra Potchanant EA, Phipps EA, Hickey RJ, and Malkas LH. Phosphorylation: the molecular switch of double-strand break repair. Int J Proteomics 373816, 2011.
116. Suzuki M, Suzuki K, Kodama S, and Watanabe M. Interstitial chromatin alteration causes persistent p53 activation involved in the radiation-induced senescence-like growth arrest. Biochem Biophys Res Commun 340: 145-150, 2006.
117. Suzuki M, Suzuki K, Kodama S, and Watanabe M. Phos-phorylated histone H2AX foci persist on rejoined mitotic chromosomes in normal human diploid cells exposed to ionizing radiation. Radiat Res 165: 269-276, 2006.
118. Tanaka T, Halicka HD, Huang X, Traganos F, and Dar-zynkiewicz Z. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 5: 1940-1945, 2006.
119. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Re-iman A, Byrd P, Taylor M, and Easton DF. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97: 813-822, 2005.
120. Uematsu N, Weterings E, Yano K, Morotomi-Yano K, Jakob B, Taucher-Scholz G, Mari PO, van Gent DC, Chen BP, and Chen DJ. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. J Cell Biol 177: 219-229, 2007.
121. Ugenskiene R, Prise K, Folkard M, Lekki J, Stachura Z, Zazula M, and Stachura J. Dose response and kinetics of foci disappearance following exposure to high-and low-LET ionizing radiation. Int J Radiat Biol 85: 872-882, 2009.
122. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22: 5612-5621, 2003.
123. van den Bosch M, Bree RT, and Lowndes NF. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep 4: 844-849, 2003.
124. van der Groep P, Hoelzel M, Buerger H, Joenje H, de Winter JP, and van Diest PJ. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer. Breast Cancer Res Treat 107: 41-47, 2008.
125. van Vuurden DG, Hulleman E, Meijer OL, Wedekind LE, Kool M, Witt H, Vandertop PW, Wurdinger T, Noske DP, Kaspers GJ, and Cloos J. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependy-moma to radiation. Oncotarget 2: 984-996, 2011.
126. Vaupel P, and Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26: 225-239, 2007.
127. Walker JR, Corpina RA, and Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412: 607-614, 2001.
128. Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Wind-hofer F, and Iliakis G. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 65: 4020-4030, 2005.
129. Wang M, Wu W, Rosidi B, Zhang L, Wang H, and Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 34: 6170-6182, 2006.
130. Ward IM, and Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 276: 47759-47762, 2001.
131. Ward IM, Minn K, Jorda KG, and Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J Biol Chem 278: 19579-19582, 2003.
132. Ward JF. The complexity of DNA damage: relevance to biological consequences. Int J Radiat Biol 66: 427-432, 1994.
133. Weber KJ, and Flentje M. Lethality of heavy ion-induced DNA double-strand breaks in mammalian cells. Int J Radiat Biol 64: 169-178, 1993.
134. Williamson CT, Muzik H, Turhan AG, Zamo A, O'Connor MJ, Bebb DG, and Lees-Miller SP. ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors. Mol Cancer Ther 9: 347-357, 2010.
135. Wu CY, Kang HY, Yang WL, Wu J, Jeong YS, Wang J, Chan CH, Lee SW, Zhang X, Lamothe B, Campos AD, Darnay BG, and Lin HK. Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem 286: 30806-30815, 2011.
136. Xu B, O'Donnell AH, Kim ST, and Kastan MB. Phosphor-ylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 62: 4588-4591, 2002.
137. Yang D, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, and Zhang W. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA 306: 1557-1565, 2011.
138. Yuan J, and Chen J. MRE11-RAD50-NBS1 complex dictates DNA repair independent of H2AX. J Biol Chem 285: 1097-1104, 2010.
139. Zhang X, Zhu Y, Geng L, Wang H, and Legerski RJ. Artemis is a negative regulator of p53 in response to oxidative stress. Oncogene 28: 2196-2204, 2009.
140. Zhao H, and Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21: 4129-4139, 2001.
141. Zirkle RE, and Tobias CA. Effects of ploidy and linear energy transfer on radiobiological survival curves. Arch Bio-chem Biophys 47: 282-306, 1953.
142. Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC, Lukas J, Bekker-Jensen S, Bartek J, and Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM-and KAP-1 dependent pathway. Nat Cell Biol 8: 870-876, 2006.
143. Zou Y, Liu Y, Wu X, and Shell SM. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J Cell Physiol 208: 267-273, 2006.